Integrating Palliative Care Social Workers Into Sub-Acute Settings: A Feasibility Trial

NCT ID: NCT03546920

Last Updated: 2019-07-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-01-08

Study Completion Date

2019-06-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a feasibility trial utilizing a step wedge design of a social worker led palliative care intervention for 120 adult patients with advanced medical illness being cared for in a subacute nursing facility. Caregivers are also invited to participate.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Of the nearly 800,000 seniors admitted to Skilled Nursing Facilities for rehabilitation (SNF rehab) annually in the U.S., approximately 20% will be newly institutionalized, 25-50% are readmitted back to the hospital within 30 days at a cost of $4.34 billion, and 9% will die in the next year. Clearly this population represents an ideal target for palliative care interventions such as decreasing symptom burden, improving quality of life, and ensuring that the medical care provided is congruent with patient goals and preferences. Unfortunately, health professionals working in the SNF rehab setting are rarely trained in palliative care. While the current standard of care in the SNF rehab setting typically includes social service assessment and case management, the care plans developed are frequently focused only on immediate, short-term issues and are not communicated as the patient is discharged to a different level of care. Existing literature supports the need to assist patients in navigating care transitions through standardized systems and patient/family activation. However, the transition from hospital to SNF and from SNF to community has received little attention, even though these are some of the most complex patients at high risk for poor outcomes. The broad goal of the research team is to optimize care for high-risk seniors admitted to SNF rehab by using a social work led, therapeutic intervention designed to align goals of care and improve communication across multiple care settings.

ALIGN (Assessing \& Listening to Individual Goals and Needs), a palliative social work led intervention, focuses on defining patient and caregiver goals and values through an ecological assessment with standardized monitoring and reassessment, providing education about disease trajectory, facilitating communication between the patient and the care team, and developing a patient-centered care plan that accompanies the patient across all future transitions. ALIGN was previously tested in a long-term acute care hospital setting as part of a quality improvement project that demonstrated decreased hospital readmissions, increased use of hospice, improved self-reported patient care experience, and higher levels of advance directive completion. This pilot study will be conducted to determine the feasibility of applying ALIGN to the SNF rehab population. The current protocol will enroll 60 patients aged 65+ at the time of admission to receive the ALIGN intervention along with at least 60 caregivers. The Investigators will also enroll 120 patients and 60 caregivers to receive care as usual. The proposed specific aims (SA) and Hypotheses (H) are:

SA1: To determine the feasibility of conducting a trial of ALIGN in older persons and their caregivers admitted to SNF rehab using a pragmatic, stepped-wedge design.

H1: The ALIGN intervention will be feasible if a) eligibility, enrollment, refusal, retention and attrition rates are within 20% of expected; b) facility staff/providers and participants (patients and caregivers) find the intervention acceptable (semi-structured qualitative interviews)

SA2: To conduct an exploratory analysis to estimate the effect size of ALIGN vs usual care on the primary patient-centered outcome, quality of life (FACT-G), and caregiver-centered outcome, caregiver burden (Zarit caregiver burden scale) and the secondary outcome (health care utilization). The investigators hypothesize that compared to control at 60-days post-enrollment, the ALIGN subjects will have:

H2a: A clinically meaningful difference in the FACT-G (3-7 points on the overall scale) for patients.

H2b: A clinically meaningful difference in the Zarit Caregiver burden scale (8±15) for caregivers.

H2c: A 20% relative decrease in 60-day readmission to hospital.

In addition to the key primary and secondary outcome measures listed above, the investigators will also explore the effect of ALIGN on utilization of palliative care/hospice, hospital length of stay, advance directive documentation, and care experience (Advanced Illness Coordinating Care Survey).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Advanced Medical Illness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SEQUENTIAL

Step wedge design. Randomization occurred at the facility level. Facilities are randomized to the order of starting accrual in control phase and then transitioning to intervention phase once control sample has accrued.
Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

This is a feasibility trial.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Control Phase

Usual care for patients admitted to the SNF.

Group Type NO_INTERVENTION

No interventions assigned to this group

ALIGN Intervention Phase

ALIGN Intervention delivered by Palliative Care Social Workers in the SNF setting. The intervention consists of aligning patient/caregiver goals of care, completing advance care planning, and connecting to community resources and services to ensure smooth transition from facility to home setting.

Group Type EXPERIMENTAL

ALIGN Intervention Phase

Intervention Type BEHAVIORAL

Communication: The PCSW will follow this structured process to improve and facilitate communication for intervention patients. 1. Attend routine weekly facility-led rounds/meetings reviewing patients, their needs and attend discharge planning conference; 2. Visit with patient and caregiver after the discharge planning conference to ensure understanding of the plan of care; 3. Ensure all appropriate community programs (home health, community palliative care) have made contact and established care, assess the transition, and revisit domains from the initial assessment; 4. Suggest questions that need to be asked of community providers. Throughout the intervention, the PCSW will communicate updates from the visits to all involved providers.

Visits will also focus on increasing goal alignment with the objective that all participants have a ROLT score that is most aligned. Visits will also explore goals of care; this includes completion or review of advance directives.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ALIGN Intervention Phase

Communication: The PCSW will follow this structured process to improve and facilitate communication for intervention patients. 1. Attend routine weekly facility-led rounds/meetings reviewing patients, their needs and attend discharge planning conference; 2. Visit with patient and caregiver after the discharge planning conference to ensure understanding of the plan of care; 3. Ensure all appropriate community programs (home health, community palliative care) have made contact and established care, assess the transition, and revisit domains from the initial assessment; 4. Suggest questions that need to be asked of community providers. Throughout the intervention, the PCSW will communicate updates from the visits to all involved providers.

Visits will also focus on increasing goal alignment with the objective that all participants have a ROLT score that is most aligned. Visits will also explore goals of care; this includes completion or review of advance directives.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

High risk for hospital readmission based on LACE Score \> 7;

* Length of stay in days,
* Caregivers must be \> 18 years old,
* Comorbidity,
* ER Visits in past 6 months)
* Admitted to SNF
* Decisional capacity to consent or proxy available to consent
* English speaking

Exclusion Criteria

* Lacking proxy available for consent
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kaiser Permanente

OTHER

Sponsor Role collaborator

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stacy M Fischer, MD

Role: PRINCIPAL_INVESTIGATOR

University of Colorado SOM

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kaiser Permanente Colorado-N/S/W

Denver, Colorado, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

17-2263

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.